尿中氯硝西泮代谢物7-氨基氯硝西泮的薄层色谱检测法

采用高效薄层色谱法检测尿中氯硝西泮代谢物7－氨基氯硝西泮（7ACLZ），分析物斑点用弗路兰进行荧光显现，灵敏度高，检出限5μg/L，定量下限15μg/L，可以检测人口服2mg氯硝西泮后48h内排泄尿的7ACLZ,适用于麻醉抢劫犯罪案件中药物检测。     

高效薄层法检测尿中氟硝西泮的代谢物7-氨基氟硝西泮

 报道了尿中氟硝西泮代谢物 7 氨基氟硝西泮 (7AFLZ)的高效薄层 (HPTLC)定性分析和半定量分析方法 ,分析物斑点用荧光胺进行荧光显现 ,灵敏度高 ,检测限 (LOD)为 5 μg/L ,测量限 (LOQ)为 15 μg/L。该方法可以检测人口服 1mg氟硝西泮后 48h内排泄尿中的 7AFLZ ,适于麻醉抢劫犯罪案件中的药物检测。     

特丁基二甲基硅烷衍生化-气相色谱-质谱联用法分析尿中硝西泮的代谢物7-氨基硝西泮

建立了用特丁基二甲基硅烷(TBDMS)衍生化-气相色谱-质谱联用分析尿中硝西泮的主要代谢物7-氨基硝西泮(7ANIZ)的高灵敏方法。方法的样品萃取率为83．6％；线性范围为10～500μg/L；检出限(LOD)为1μg/L;定量限(LOQ)为3μg/L；RSD为3．6％-5．8％，回收率为96．3％-102．6％。对口服10mg硝西泮者96h内所排泄的尿液进行了7ANIZ检测，结果表明：本方法能满足司法鉴定的要求。     

气相色谱电子捕获检测法测定人尿中氟硝西泮的代谢物7-氨基氟硝西泮

采用气相色谱电子捕获检测法测定人尿中氟硝西泮的代谢物 7 氨基氟硝西泮。测定时尿中加入内标 7 氨基硝西泮 ,用β 葡萄糖醛酸苷酶水解及碱性液液萃取 ,再用七氟丁酸酐衍生化。尿中 7 氨基氟硝西泮提取率为 96.8% ;回收率为 98.6± 3 .4% (平均值±SD) ;检出限为 1 .2 μg L ,对口服治疗量氟硝西泮的人尿进行检测 ,可检出服药后 60h尿中的 7 氨基氟硝西泮。     

自动固相萃取/液相色谱-串联质谱法测定血液中氯硝西泮及其代谢产物7-氨基氯硝西泮

建立了血液中氯硝西泮及其代谢产物7-氨基氯硝西泮的自动固相萃取/液相色谱-串联质谱(ASPE/LC-MS/MS)分析方法。样品经C18固相萃取柱提取后,采用LC-MS/MS进行测定,外标法定量。在Waters Atlantis TM d C18反相柱上分离,梯度洗脱,流动相为甲醇和0.1%甲酸水溶液,质谱采集为电喷雾正离子多反应监测模式。2种目标物在2~1 000μg/L范围内具有良好的线性关系,相关系数为0.995 9~0.998 2,检出限为0.2~0.5μg/L;加标水平为50,200,1 000μg/L时,方法的回收率为72.6%~96.3%,相对标准偏差为4.2%~10.3%。本方法可用于法庭与临床的毒物分析。     

氯硝西泮及其代谢产物7-氨基氯硝西泮的化学合成

以2-氰基-4-硝基苯胺为原料,经氧化偶联、酰胺化、亲核取代反应、分子内Wittig反应、还原反应等过程实现了7-氨基氯硝西泮的化学合成,在反应完成后可以直接过滤淋洗即可得到产物,无需其他纯化,操作简便。     

三甲基硅烷衍生化-气相/质谱联用法分析尿中7-氨基硝西泮

 建立了分析尿中硝西泮主要代谢物 7 氨基硝西泮 (7 ANIZ)的三甲基硅烷衍生化 气相 /质谱联用方法。尿样经乙醚 乙酸乙酯 (体积比为 99∶1 )萃取后 ,用N ,O 双 (三甲基硅 )三氟乙酰胺进行衍生化 ,检测衍生物的总离子流。根据 7 ANIZ衍生物质谱中主要特征离子的相对丰度及其质量的保留时间进行定性分析 ;用 7 氨基氯硝西泮做内标 ,根据衍生物基峰离子的质量进行定量分析。本方法中 7 ANIZ的萃取率为 82 8% ,线性范围为 1 0 μg/L～ 50 0 μg/L,检出限为 1 2 μg/L,定量限为 3 5μg/L。     

硝西泮、氯硝西泮甲基衍生物的气相色谱-质谱分析

对硝西泮和氯硝西泮的衍生化条件、色谱及质谱行为进行了研究,确立了猪肉中硝西泮、氯硝西泮残留的GC-MS检测方法.应用5因素4水平的正交试验,最终确定衍生化条件为反应温度60℃、反应时间30 min、丙酮用量0.5 mL、衍生化试剂20μL、催化剂无水碳酸钾20mg,在此条件下可生成较完全的甲基衍生物.衍生物具有较好的气相色谱和电子轰击质谱行为.硝西泮衍生物的分子离子峰为m/z 295,基峰离子为m/z 267,主要碎片离子分别为m/z 206、220、248、294;氯硝西泮衍生物的分子离子峰为m/z 329,基峰离子为m/z 328,主要碎片离子分别为m/z205、220、248、266、294、331,并对这些离子的产生进行了解析.这些离子均具有较强的相对丰度,可作为其微量检测的多离子选择定性和确证,而基峰离子可用于单离子选择定量.用乙腈提取药物,C18固相萃取柱净化,GC-MS分析.本方法采用外标法定量,两种药物的标准曲线线性回归系数均在0.99以上,线性范围20～500 μg/L,回收率80%左右,相对标准偏差6.9%～14.9%,检出限16.7 μg/kg.     

胶束液相色谱法同时测定血浆中的苯巴比妥、艾司唑仑和氯硝西泮

采用胶束液相色谱法(MLC)分离测定血浆中苯巴比妥、艾司唑仑和氯硝西泮,运用三相平衡理论探讨了流动相中表面活性剂浓度(CM)、氢离子浓度(CH)、助表面活性剂浓度(Cφ)对溶质保留行为的影响,同时运用多元线性回归建立了保留因子的对数(log k)与溶质性质参数和流动相组成之间的相关模型。结果表明,溶质保留因子(k)随CM、Cφ和CH的增加而减小,与理论模型完全一致。而且log k与溶质的疏水性常数的对数(log P)和电离常数(Ka)以及CM、CH和Cφ之间呈现良好的多元线性关系。在确定的色谱条件下,血浆中的3种药物与其他组分之间有较好的分离效果。3种药物的血药浓度分别在2.5～50 mg/L、0.25～5.0 mg/L和0.05～5.0 mg/L间具有良好的线性关系。本方法简便、准确、重现性良好、灵敏度高。3种药物的最低检出限(S/N=3)分别为10.27、1.17、0.867 ng,平均加标回收率范围分别为99.80%～102.9%, 94.00%～98.20%和96.30%～98.70%。     

2-氨基-4-氯-5-甲基苯磺酸的合成研究

2 氨基 4 氯 5 甲基苯磺酸是合成染料和颜料的重要中间体 ,主要用于合成Ｃ .Ｉ.颜料红等[1] 。目前该产品的合成是以对硝基甲苯为原料 ,经氯化、还原、磺化而成[2 ] 。磺化过程需在压力容器中进行 ,存在成本高 ,溶剂及副产物二氯苯、多氯联苯有毒等问题[3,4] 。为此采用无毒、价廉的汽油和石油醚作为混合溶剂 ,常压下合成 2 氨基 4 氯 5 甲基苯磺酸是本工作的目的。1　实验部分1 .1　主要仪器和药品Ｘ4熔点测定仪 ,日本 2 6 0 5 0型红外光谱仪 ,日本ＬＣ 6Ａ高效液相色谱仪 ,ＪＥＯＬＦＸ 90Ｑ型核磁共振光谱仪 ,美国ＰＥ 2 4 0 0自动元…     

虾仁中氯霉素残留量的气相色谱测定

建立了用配有电子俘获检测器(ECD)的气相色谱仪来测定虾仁中的氯霉素含量的方法.试样用乙酸乙酯提取,正己烷去杂,硅胶柱纯化,BSTFA+TMCS(99:1)试剂硅烷化.以GC ECD方式测定,外标法定量.当添加水平为0.2×10-9～1.0×10-9μg/kg时,回收率为70%～110%;相对标准偏差为1.0%～5.0%;线性相关系数r大于0.998.     

Determination of the 7-amino-metabolites of the 7-nitro-benzodiazepines in human plasma by thin-layer chromatography

A sensitive thin-layer chromatographic method is described for the determination of the 7–amino-metabolites of flunitrazepam and clonazepam. The same procedure is applicable to other 7-nitro-benzodiazepines such as nitrazepam. A purified plasma extract of the 7-amino-metabolites is separated by thin-layer chromatography. The primary aromatic amines are diazotized and coupled with N-(1-naphthyl) ethylene-diamine on the thin-layer plate. The quantities of the 7-amino-metabolites are directly evaluated by colorimetric densitometry. The lower limit of detection is in order of 0.5–10 ng cm^?3 of plasma. The relative standard deviation of the whole procedure is less than ±15% in the range of 0.5–10 ng cm^?3 for a single determination. The unchanged drugs can be reduced on the thin-layer plate and detected by the same method. Since this procedure is rather difficult to perform, it is advantageous to determine the 7-nitro-benzodiazepines in plasma by gas chromatography. The thin-layer chromatographic method was used to measure the 7-amino-metabolites in plasma of patients on either a flunitrazepam or a clonazepam oral dosing regimen.     

Selective extraction of clonazepam from human plasma and urine samples by molecularly imprinted polymeric beads

A molecularly imprinted polymer (MIP) based on free‐radical polymerization was prepared with 1‐(N,N‐biscarboxymethyl)amino‐3‐allylglycerol and N,N‐dimethylacrylamide as functional monomers, N,N‐methylene diacrylamide as the cross‐linker, copper ion‐clonazepam as the template and 2,2‐azobis(2‐methylbutyronitrile) as the initiator. The imprinted polymer was characterized by Fourier transform infrared spectroscopy, elemental analysis, thermogravimetric analysis, and SEM. The MIP of agglomerated microparticles with multipores was used for SPE. The imprinted polymer sorbent was selective for clonazepam. The optimum pH and sorption capacity were 5 and 0.18 mg/g at 20°C, respectively. The profile of the drug uptake by the sorbent reflects good accessibility of the active sites in the imprinted polymer sorbent. The MIP‐SPE was the most feasible technique for the extraction of clonazepam with a high recovery from human plasma and urine samples.     

Determination of calycosin-7-O-beta-D-glucopyranoside in rat plasma and urine by HPLC

A reversed-phase high-performance liquid chromatographic (HPLC) assay for calycosin-7-O-beta-D-glucopyranoside in rat plasma and urine with solid-phase extraction (SPE) was developed. Rutin was employed as an internal standard. The mobile phase consisted of acetonitrile-water (16:84, v/v) at a flow rate of 1.0 mL/min. Detection was set at 280 nm. The limit of quantitation of calycosin-7-O-beta-D-glucopyranoside was 0.2 microg/mL in both plasma and urine. The standard curve was linear from 0.2 to 10.0 microg/mL in plasma, and 0.2 to 5.0 microg/mL in urine. Both intra- and inter-day precision of the calycosin-7-O-beta-d-glucopyranoside were determined and their RSD did not exceed 10%. The method was successfully applied to the analysis of samples obtained from a basic pharmacokinetic study, in which calycosin-7-O-beta-d-glucopyranoside was administered orally to rats.     

土壤中17种有机氯农药残留量的毛细管气相色谱测定法

采用专用索氏提取器、正己烷萃取、Elite-5MS弹性石英毛细柱分离、GC-ECD测定了土壤中17种有机氯农药残留量.方法的检出限为0.4×10-10～2.0×10-10 g,回收率范围在76.0%～108.9%之间,相对标准偏差为0.66%～9.10%.该方法适用于土壤有机氯农药残留量的分析.     

Determination of trichlormethiazide in human plasma and urine by high-performance liquid chromatography

Summary This paper describes a high-performance liquid chromatographic (HPLC) assay method for the determination of trichlormethiazide (TCM) in human plasma and urine. After extraction and separation on an ODS column TCM from plasma was detected by oxidation in an electrochemical detector (ECD) by a porous graphite electrode. The sensitivity was better than HPLC with UV detection, enabling the determination of 2 ng ml^–1 TCM in human plasma. This method also allows determination of TCM at higher concentrations by exchanging the UV for the electrochemical detector. To study the pharmacokinetics, TCM in plasma and urine was assayed with coefficients of variation in the range 2–3%. The method has the advantages of high sensitivity for plasma assay and high precision with a simple procedure for both plasma and urine samples. Small samples of 0.5 ml plasma per assay also reduced the total volume of plasma needed.     

气相色谱-电子捕获检测器同时测定茶叶中有机氯及拟除虫菊酯类农药残留

在超声波辅助下,以正己烷-二氯甲烷（1：1,V／V）混合溶剂提取样品,提取液用弗罗里硅土和中性氧化铝混合柱净化,用气相色谱-电子捕获检测器（GC-ECD）同时测定茶叶中18种有机氯和9种拟除虫菊酯类农药残留。有机氯农药在0.001-0.2μg／mL,拟除虫菊酯类农药在0.005-1.0μg／mL范围内线性良好。有机氯农药在0.04、0.01μg／mL两个添加水平的回收率分别为89.5％-113.2％和80.0％-112.7％,相对标准偏差分别为3.82％-9.64％和5.32％-13.8％。拟除虫菊酯在0.2、O.05μg／mL两个添加水平的回收率分别为97.5％-129.6％和87.3％-110.2％,相对标准偏差分别为3.78％-10.72％和3.02％-13.84％。本方法快速、灵敏、准确、可靠,用于江西茶叶样品中有机农药残留测定,获得较好结果。     

Characterization of Semtex by supercritical fluid extraction and off-line GC-ECD and GC-MS

Researchers using electron capture for the detection of explosive vapors currently claim the ability to detect the presence of RDX in Semtex – a plastic explosive comprising hexahydro-1,3,5-trinitro-1,3,5-triazane (RDX) in a matrix of styrene-butadiene copolymer and hydrocarbon oil. The vapor pressure of RDX at room temperature is 0.006 ppb, and therefore well below the detection limit of electron capture detection (ECD). The positive response generated by ECD is, consequently, not from the presence of RDX, but from some other component. This paper describes the extraction and identification of several compounds in Semtex, along with the determination of which is responsible for the positive response of an ECD-based detector. From the results of supercritical fluid extraction and off-line gas chromatography combined with electron capture and mass spectrometric detection, it has been concluded that ethylene glycol dinitrate is the component responsible for the positive ECD response. This conclusion is based on the requirements necessary for ECD detection, i.e. electronegativity, and a sufficient vapor pressure. The other compounds present were eliminated as possible choices because they either can not be detected by an ECD or do not have sufficient vapor pressure under ambient conditions.